APA (7th ed.) Citation

LV, R., SA, W., M, K., K, M., J, C., R, B., . . . R, C. B. (2026). Long-term outcomes in triple-negative breast cancer after a pathologic complete response: Does the type of neoadjuvant therapy matter? Breast cancer research and treatment, 217(2), . https://doi.org/10.1007/s10549-026-07963-z

Chicago Style (17th ed.) Citation

LV, Ravani, et al. "Long-term Outcomes in Triple-negative Breast Cancer After a Pathologic Complete Response: Does the Type of Neoadjuvant Therapy Matter?" Breast Cancer Research and Treatment 217, no. 2 (2026). https://doi.org/10.1007/s10549-026-07963-z.

MLA (9th ed.) Citation

LV, Ravani, et al. "Long-term Outcomes in Triple-negative Breast Cancer After a Pathologic Complete Response: Does the Type of Neoadjuvant Therapy Matter?" Breast Cancer Research and Treatment, vol. 217, no. 2, 2026, https://doi.org/10.1007/s10549-026-07963-z.